103 related articles for article (PubMed ID: 1511036)
1. A sensitive and reproducible HPLC assay for doxorubicin and pirarubicin.
Jacquet JM; Galtier M; Bressolle F; Jourdan J
J Pharm Biomed Anal; 1992 May; 10(5):343-8. PubMed ID: 1511036
[TBL] [Abstract][Full Text] [Related]
2. LC-MS/MS method development for quantification of doxorubicin and its metabolite 13-hydroxy doxorubicin in mice biological matrices: Application to a pharmaco-delivery study.
Mazzucchelli S; Ravelli A; Gigli F; Minoli M; Corsi F; Ciuffreda P; Ottria R
Biomed Chromatogr; 2017 Apr; 31(4):. PubMed ID: 27714830
[TBL] [Abstract][Full Text] [Related]
3. HPLC method development and validation for simultaneous detection of Arabinoside-C and doxorubicin.
Mistiran AF; Dzarr AA; Gan SH
Toxicol Mech Methods; 2010 Oct; 20(8):472-81. PubMed ID: 20626302
[TBL] [Abstract][Full Text] [Related]
4. [Detecting doxorubicin concentration in KBv200 and KB cell xenografts in nude mice by high-performance liquid chromatography].
Deng WJ; Zeng ZL; Liang YJ; Dai CL; Zhang JY; Fu LW
Ai Zheng; 2008 Apr; 27(4):364-8. PubMed ID: 18423121
[TBL] [Abstract][Full Text] [Related]
5. Optimization of LC method for the quantification of doxorubicin in plasma and urine samples in view of pharmacokinetic, biomedical and drug monitoring therapy studies.
Maliszewska O; Plenis A; Olędzka I; Kowalski P; Miękus N; Bień E; Krawczyk MA; Adamkiewicz-Drożynska E; Bączek T
J Pharm Biomed Anal; 2018 Sep; 158():376-385. PubMed ID: 29936377
[TBL] [Abstract][Full Text] [Related]
6. Determination of doxorubicin and metabolites in murine specimens by high-performance liquid chromatography.
van Asperen J; van Tellingen O; Beijnen JH
J Chromatogr B Biomed Sci Appl; 1998 Aug; 712(1-2):129-43. PubMed ID: 9698235
[TBL] [Abstract][Full Text] [Related]
7. Determination of epirubicin and its metabolite epirubicinol in saliva and plasma by HPLC.
Dodde WI; Maring JG; Hendriks G; Wachters FM; Groen HJ; de Vries EG; Uges DR
Ther Drug Monit; 2003 Aug; 25(4):433-40. PubMed ID: 12883225
[TBL] [Abstract][Full Text] [Related]
8. High-performance liquid chromatographic validated assay of doxorubicin in rat plasma and tissues.
Alvarez-Cedrón L; Sayalero ML; Lanao JM
J Chromatogr B Biomed Sci Appl; 1999 Jan; 721(2):271-8. PubMed ID: 10052699
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of the lipophilic doxorubicin analogue annamycin in plasma and tissue samples by reversed-phase chromatography.
Zou Y; Hayman A; Priebe W; Perez-Soler R
J Pharm Sci; 1993 Nov; 82(11):1151-4. PubMed ID: 8289131
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a LC-FL method for the simultaneous determination of doxorubicin and celecoxib in nanoparticulate fixed dose combination (NanoFDC).
Kozlu S; Sahin A; Calis S; Capan Y
Pharmazie; 2017 Oct; 72(10):568-570. PubMed ID: 29441879
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous high-performance liquid chromatographic determination of a glucuronyl prodrug of doxorubicin, doxorubicin and its metabolites in human lung tissue.
Mürdter TE; Sperker B; Bosslet K; Fritz P; Kroemer HK
J Chromatogr B Biomed Sci Appl; 1998 May; 709(2):289-95. PubMed ID: 9657226
[TBL] [Abstract][Full Text] [Related]
12. A sensitive high performance liquid chromatography assay for the quantification of doxorubicin associated with DNA in tumor and tissues.
Lucas AT; O'Neal SK; Santos CM; White TF; Zamboni WC
J Pharm Biomed Anal; 2016 Feb; 119():122-9. PubMed ID: 26678179
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous liquid chromatographic determination of doxorubicin and its major metabolite doxorubicinol in parrot plasma.
Gilbert CM; McGeary RP; Filippich LJ; Norris RL; Charles BG
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 826(1-2):273-6. PubMed ID: 16168722
[TBL] [Abstract][Full Text] [Related]
14. HPLC quantification of doxorubicin in plasma and tissues of rats treated with doxorubicin loaded poly(alkylcyanoacrylate) nanoparticles.
Alhareth K; Vauthier C; Gueutin C; Ponchel G; Moussa F
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 887-888():128-32. PubMed ID: 22341684
[TBL] [Abstract][Full Text] [Related]
15. Determination of doxorubicin and doxorubicinol in plasma of cancer patients by high-performance liquid chromatography.
de Bruijn P; Verweij J; Loos WJ; Kolker HJ; Planting AS; Nooter K; Stoter G; Sparreboom A
Anal Biochem; 1999 Jan; 266(2):216-21. PubMed ID: 9888978
[TBL] [Abstract][Full Text] [Related]
16. High-performance liquid chromatographic determination of 4-amino-5-chloro-N-[(1-ethylimidazolin-2-yl)methyl]-2-methoxybenzamide and its metabolite in biological fluids. Applications in pharmacokinetic studies.
Bressolle F; Bres J; Moulin A
J Pharm Sci; 1990 Jun; 79(6):534-9. PubMed ID: 2395100
[TBL] [Abstract][Full Text] [Related]
17. Validation and clinical evaluation of a UHPLC method with fluorescence detector for plasma quantification of doxorubicin and doxorubicinol in haematological patients.
Pérez-Blanco JS; Fernández de Gatta Mdel M; Hernández-Rivas JM; García Sánchez MJ; Sayalero Marinero ML; González López F
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Apr; 955-956():93-7. PubMed ID: 24631816
[TBL] [Abstract][Full Text] [Related]
18. HPLC determination of doxorubicin, doxorubicinol and four aglycone metabolites in plasma of AIDS patients.
Beijnen JH; Meenhorst PL; van Gijn R; Fromme M; Rosing H; Underberg WJ
J Pharm Biomed Anal; 1991; 9(10-12):995-1002. PubMed ID: 1822225
[TBL] [Abstract][Full Text] [Related]
19. Analysis of iododoxorubicin and its major impurity.
Farina A; Quaglia MG; Bossù E; Melchiorre P
J Pharm Biomed Anal; 1991; 9(10-12):1165-8. PubMed ID: 1822190
[No Abstract] [Full Text] [Related]
20. Accelerator mass spectrometry allows for cellular quantification of doxorubicin at femtomolar concentrations.
DeGregorio MW; Dingley KH; Wurz GT; Ubick E; Turteltaub KW
Cancer Chemother Pharmacol; 2006 Feb; 57(3):335-42. PubMed ID: 16047147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
